Literature DB >> 30889582

Incidence, Risk factors, and Biomarkers Predicting Ischemic or Hemorrhagic Stroke Associated Acute Kidney Injury and Outcome: A Retrospective Study in a General Intensive Care Unit.

Fang Jiang1, Lianjiu Su1, Hui Xiang1, Xiaoyi Zhang1, Dongxue Xu1, Zhongxiang Zhang1, Zhiyong Peng2.   

Abstract

OBJECTIVE: We investigated the epidemiology, risk factors, and predictive parameters for ischemic or hemorrhagic stroke-associated acute kidney injury (AKI) and mortality in a general intensive care unit (ICU) in China.
METHODS: During 5 years, 479 stroke patients were screened, and 381 were enrolled. AKI was diagnosed within 7 days after ICU admission, based on the Kidney Disease Improving Global Outcomes criteria. Risk factors of AKI were assessed by Logistic regression analyses, and the predictive biomarkers for AKI were determined using receiver operating characteristic (ROC) curves. Also examined were factors influencing 28-day mortality, using Cox regression analyses and Kaplan-Meier curves. -
Results: Among all, 115 (30.18%) patients developed AKI. Multivariate regression analyses revealed that the following features at ICU admission significantly increased the risk of developing AKI: an increased National Institutes of Health Stroke Scale score (OR 1.136, p < 0.001) and Acute Physiology and Chronic Health Evaluation II score (OR 1.107, p = 0.042); hypertension (OR 2.346, p = 0.008); use of loop diuretics (OR 1.961, p = 0.032); and higher serum cystatin C (sCysC; OR 8.156, p = 0.001). The area under the ROC curves for predicting AKI using sCysC was 0.772, slightly better than that of other biomarkers. The sCysC ≥0.93 mg/L (hazard ratio 1.844, p = 0.004) significantly predicted 28-day mortality.
CONCLUSIONS: Among stroke patients in ICU, we identified significant risk factors of stroke-associated AKI. Serum CysC level at ICU admission was an important biomarker for predicting AKI and 28-day mortality.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  28-day mortality; Acute kidney injury; Critical illness; Serum cystatin C; Stroke

Year:  2019        PMID: 30889582     DOI: 10.1159/000499029

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  7 in total

Review 1.  Peripheral Organ Injury After Stroke.

Authors:  Jin Wang; Jiehua Zhang; Yingze Ye; Qingxue Xu; Yina Li; Shi Feng; Xiaoxing Xiong; Zhihong Jian; Lijuan Gu
Journal:  Front Immunol       Date:  2022-06-01       Impact factor: 8.786

2.  Construction of a Glycaemia-Based Signature for Predicting Acute Kidney Injury in Ischaemic Stroke Patients after Endovascular Treatment.

Authors:  Chengfang Liu; Xiaohui Li; Zhaohan Xu; Yishan Wang; Teng Jiang; Meng Wang; Qiwen Deng; Junshan Zhou
Journal:  J Clin Med       Date:  2022-07-03       Impact factor: 4.964

3.  The Monocyte-to-Lymphocyte Ratio Predicts Acute Kidney Injury After Acute Hemorrhagic Stroke.

Authors:  Fen Jiang; Jialing Liu; Xin Yu; Rui Li; Run Zhou; Jianke Ren; Xiangyang Liu; Saili Zhao; Bo Yang
Journal:  Front Neurol       Date:  2022-06-20       Impact factor: 4.086

4.  Glycerol Improves Intracerebral Hemorrhagic Brain Injury and Associated Kidney Dysfunction in Rats.

Authors:  Cheng-Yi Chang; Ping-Ho Pan; Jian-Ri Li; Yen-Chuan Ou; Su-Lan Liao; Wen-Ying Chen; Yu-Hsiang Kuan; Chun-Jung Chen
Journal:  Antioxidants (Basel)       Date:  2021-04-19

5.  Association of Prior to Intensive Care Unit Statin Use With Outcomes on Patients With Acute Kidney Injury.

Authors:  Boxiang Tu; Yuanjun Tang; Yi Cheng; Yuanyuan Yang; Cheng Wu; Xiaobin Liu; Di Qian; Zhansai Zhang; Yanfang Zhao; Yingyi Qin; Jia He
Journal:  Front Med (Lausanne)       Date:  2021-12-24

6.  Renal safety evaluation of aspirin plus edaravone in patients with ischaemic stroke: a retrospective cohort study.

Authors:  Hui-Qin Yang; Wen-Jun Yin; Kun Liu; Man-Cang Liu; Xiao-Cong Zuo
Journal:  BMJ Open       Date:  2022-04-19       Impact factor: 3.006

7.  Acute kidney injury after a stroke: A PRISMA-compliant meta-analysis.

Authors:  Yong Huang; Chanjun Wan; Guoqing Wu
Journal:  Brain Behav       Date:  2020-08-05       Impact factor: 2.708

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.